These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28099271)

  • 1. Innovative strategies for adverse karyotype acute myeloid leukemia.
    Blum S; Greve G; Lübbert M
    Curr Opin Hematol; 2017 Mar; 24(2):89-98. PubMed ID: 28099271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in acute myeloid leukemia.
    Kadia TM; Ravandi F; O'Brien S; Cortes J; Kantarjian HM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):139-51. PubMed ID: 25441110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
    Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
    Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia: 2019 update on risk-stratification and management.
    Estey EH
    Am J Hematol; 2018 Oct; 93(10):1267-1291. PubMed ID: 30328165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly targeted therapy in acute myeloid leukemia.
    Gill H; Leung AY; Kwong YL
    Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs.
    Bernardi M; Carrabba M; Messina C; Milani R; Sala E; Pavesi F; Gentner B; Peccatori J; Assanelli A; Marktel S; Corti C; Forcina A; Vago L; Ciceri F
    Am J Hematol; 2016 Jun; 91(6):E302-3. PubMed ID: 26928240
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?
    Finn LE; Foran JM
    Curr Opin Hematol; 2016 Mar; 23(2):95-101. PubMed ID: 26825695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing therapy for acute myeloid leukemia.
    Kohrt HE; Coutre SE
    J Natl Compr Canc Netw; 2008 Nov; 6(10):1003-16. PubMed ID: 19176198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?
    Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
    Ferrara F
    Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.
    Montesinos P; Bergua J; Infante J; Esteve J; Guimaraes JE; Sierra J; Sanz MÁ
    Ann Hematol; 2019 Nov; 98(11):2467-2483. PubMed ID: 31667544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting maintenance therapy in acute myeloid leukemia with novel agents.
    Canaani J; Luger SM
    Curr Opin Hematol; 2016 Mar; 23(2):175-80. PubMed ID: 26766539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfavorable, complex, and monosomal karyotypes: the most challenging forms of acute myeloid leukemia.
    Orozco JJ; Appelbaum FR
    Oncology (Williston Park); 2012 Aug; 26(8):706-12. PubMed ID: 22957403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to patients with primary refractory acute myeloid leukemia.
    Orlowski RJ; Mangan JK; Luger SM
    Curr Opin Hematol; 2015 Mar; 22(2):97-107. PubMed ID: 25575037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute myeloid Leukemia].
    Braess J
    Dtsch Med Wochenschr; 2016 Nov; 141(24):1748-1751. PubMed ID: 27835920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.